Status
Conditions
Treatments
About
The goal of this clinical trial is to test whether financial support in the form of a one-time $500 stipend would improve medication adherence and quality of life in low-income, socially-needy patients with heart failure with reduced ejection fraction in the post-discharge setting. The main questions it aims to answer are:
Participants will complete surveys on quality of life, social stress, and spending habits at their baseline visit. Participants will be randomly assigned to receive $500 at their baseline visit or $0 at their baseline visit. At their one month visit, quality of life and medication adherence will be assessed. These results will be compared between groups. The group that received $0 at their baseline visit will be provided $500 at their one-month visit and return for a two-month visit. At that visit, quality of life and medication adherence will be assessed. These results will be compared to their one-month results.
Researchers will compare the 1-month quality of life scores and medication adherence scores between the immediate financial support vs delayed financial support. Researchers will also compare 1-month vs 2-month quality of life and adherence data for participants who were randomized to the delayed financial support group.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Age > 18
English speaking participants who completed SOCIAL-HF study surveys
Ejection Fraction <=40% and eligible for at least one component of GDMT
Has at least some difficulty paying monthly bills (Somewhat Difficult and Very Difficult)
Annual household income <130% Federal Poverty Limit
Have at least two additional social needs based on the following domains:
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
153 participants in 2 patient groups
Loading...
Central trial contact
Ambarish Pandey, MD, MSCS
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal